Recently, I had a phone conversation with Marc Hendriks, R&D and technology director at DSM Biomedical. Hendriks had just announced over Twitter that he had recently given a guest lecture at the University of California, Berkeley and I was curious about the contents of his presentation.
While giving me a summary of his biomaterials lecture over the phone, It was clear that Hendriks, who has a doctorate in chemical engineering and holds 25 U.S. patents, is a real expert on the subject. By the end of our conversation, I had an invitation to send over a few questions, the answers to which I planned on sharing with our readers.
The result of that exchange exceded my already high expectations. I present here his in-depth response to each of the four broad questions I asked:
- How do you envision that biomaterials will help address medical applications in the near future and longer term?
- Could you explain what you mean when you refer to three generations of biomaterials?
- How has biomaterials research transformed orthopedics and cardiovascular devices?
- Could you give us an overview of biomaterials’ current and likely future role in tissue engineering?